Lead story · 2026·08·08 · 06:01 UTC

Kalshi and Polymarket bets on clinical trials criticized as 'ghastly' - npr.org

Discovery Search

This cluster tracks updates related to Kalshi and Polymarket bets on clinical trials criticized as 'ghastly' - npr.org. Coverage began with: Kalshi and Polymarket bets on clinical trials criticized as 'ghastly' - npr.org. Latest coverage: Kalshi and Polymarket bets on clinical trials criticized as 'ghastly' - npr.org.

Chronology
Timeline
Related stories

Read the prediction-market beat

Free, no signup needed. We do the cross-source comparison so you don't have to.

Browse latest